Feb 4 (Reuters) - Industrial equipment maker IDEX Corp IEX.N reported a better-than-expected quarterly profit on Tuesday, driven by strong sales of its health and science technology segment products.
Quarterly sales in IDEX's health and sciences technology segment, which includes components and equipment used in clinical diagnostics and drug discovery, as well as in the food processing and cosmetic manufacturing industries, rose 19.3%.
The rise in demand was led by sellers seeking to replenish inventories following an extended destocking cycle triggered by large stockpiles during the COVID-19 pandemic.
Quarterly adjusted earnings per share stood at $2.04, compared with Wall Street estimates of $2.02, according to data compiled by LSEG.
Total revenue for the fourth quarter ended Dec. 31 was $862.9 million, up about 9% from a year earlier. Analysts, on average, were expecting revenue of $863.8 million in the fourth quarter.
(Reporting by Aishwarya Jain and Nathan Gomes; Editing by Mohammed Safi Shamsi)
((Aishwarya.Jain@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。